Description
EMPAFLO-L Tablets 10mg + 5mg (30’s pack) combine Empagliflozin and Linagliptin to provide effective treatment for type 2 diabetes mellitus. Each tablet contains 10mg of Empagliflozin, an SGLT2 inhibitor that promotes glucose elimination through the kidneys, and 5mg of Linagliptin, a DPP-4 inhibitor that increases insulin release and decreases glucagon levels in the blood.
This combination works synergistically to improve blood sugar control, support weight management, and may reduce cardiovascular risks associated with diabetes. The 30-tablet pack offers a convenient supply for regular therapy.
Manufactured under strict quality standards, EMPAFLO-L Tablets ensure safety, efficacy, and consistent therapeutic outcomes. Patients should take the medication as prescribed by their healthcare provider and maintain a healthy lifestyle to maximize benefits.
Reviews
There are no reviews yet.